2020

Prostate Cancer Foundation (PCF) 2019 Guide

Every year, the PCF publishes an electronic guide providing information on all aspects of prostate cancer. The chapters covered are as follows. General information including diagnosis, symptoms, risk factors, and medical basics. Information for the newly diagnosed, including detection, diagnosis and treatment selection. Treatment options for localized or locally advanced prostate cancer. These include active more »

Pyl Imaging Agent Accurately Detects Recurrent Prostate Cancer Lesions

Progenics Pharmaceuticals’ PyL, a new imaging agent for positron emission tomography (PET) scans, can accurately detect the location of recurrent prostate cancer lesions, according to data from the Phase 3 CONDOR clinical trial. “There is a need for improved diagnostics for prostate cancer to replace conventional imaging tests that have limited performance characteristics, especially in more »